BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22922441)

  • 21. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
    Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited efficacy of rapamycin monotherapy in vascularized composite allotransplantation.
    Xu H; Steinberger Z; Wang L; Han R; Zhang Y; Hancock WW; Levin LS
    Transpl Immunol; 2020 Aug; 61():101308. PubMed ID: 32535143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone deacetylase inhibition is cytotoxic to oligodendrocyte precursor cells in vitro and in vivo.
    Dincman TA; Beare JE; Ohri SS; Gallo V; Hetman M; Whittemore SR
    Int J Dev Neurosci; 2016 Nov; 54():53-61. PubMed ID: 27587342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
    Zhou Q; Dalgard CL; Wynder C; Doughty ML
    BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-responsive gene expression in suberoylanilide hydroxamic acid-treated resting CD4+ T cells.
    Reardon B; Beliakova-Bethell N; Spina CA; Singhania A; Margolis DM; Richman DR; Woelk CH
    AIDS; 2015 Nov; 29(17):2235-44. PubMed ID: 26258524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirtinol regulates the balance of Th17/Treg to prevent allograft rejection.
    Ye Q; Zhang M; Wang Y; Fu S; Han S; Wang L; Wang Q
    Cell Biosci; 2017; 7():55. PubMed ID: 29090089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
    You BR; Han BR; Park WH
    Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
    Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
    Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects and mechanisms of tacrolimus on development of murine Th17 cells.
    Zhang XJ; Kang YD; Xiao L; Li RD; Ding GS; Wang ZX; Fu ZR
    Transplant Proc; 2010 Nov; 42(9):3779-83. PubMed ID: 21094856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo.
    Zheng L; Fu Y; Zhuang L; Gai R; Ma J; Lou J; Zhu H; He Q; Yang B
    Int J Cancer; 2014 Oct; 135(7):1721-32. PubMed ID: 24615207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity.
    Wu J; Zhou C; Chen W; Xie A; Li J; Wang S; Ye P; Wang W; Xia J
    Transplantation; 2013 Feb; 95(3):434-41. PubMed ID: 23296151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
    Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
    Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.
    Bieliauskas AV; Weerasinghe SV; Negmeldin AT; Pflum MK
    Arch Pharm (Weinheim); 2016 May; 349(5):373-82. PubMed ID: 27062198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
    Qiu X; Rong X; Yang J; Lu Y
    BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.
    Jin JS; Tsao TY; Sun PC; Yu CP; Tzao C
    Pathol Oncol Res; 2012 Jul; 18(3):713-20. PubMed ID: 22270866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.
    Zhou W; Zhou X; Gaowa S; Meng Q; Zhan Z; Liu J; Li J; Fan H; Liu Z
    Transplantation; 2015 Jul; 99(7):1356-64. PubMed ID: 25856405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.